Advanced Biofuels

Dyadic International Raises $3 Million in Convertible Note Placement

Date Posted: October 11, 2011

Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries, announced Oct. 5 that it has completed a private placement of $3,000,000 in convertible subordinated secured promissory notes (the “Notes”) to five investors.

The Notes will pay interest quarterly at a rate of 8% per annum and are convertible at the holder’s option into shares of Dyadic common stock.

Unless converted, the Notes will mature on January 1, 2013.

Dyadic expects to use proceeds from this offering for working capital including continued investments in research and development, new product introductions and general corporate purposes.

For more information, call 561-743-8333.

See Related Websites/Articles:

more ADVANCED BIOFUELS...